APA (7th ed.) Citation

Klyueva, S. N., Budanova, A. A., Kravtsov, A. L., & Bugorkova, S. A. (2025). Possibilities and prospects of using biofluorescent proteins at the stage of preclinical evaluation of live vaccines, using the example of the <i>Yersinia pestis</i> vaccine strain EV NIIEG pTURBOGFP-B. Central Research Institute for Epidemiology.

Chicago Style (17th ed.) Citation

Klyueva, Svetlana N., Angelina A. Budanova, Aleksandr L. Kravtsov, and Svetlana A. Bugorkova. Possibilities and Prospects of Using Biofluorescent Proteins at the Stage of Preclinical Evaluation of Live Vaccines, Using the Example of the <i>Yersinia Pestis</i> Vaccine Strain EV NIIEG PTURBOGFP-B. Central Research Institute for Epidemiology, 2025.

MLA (9th ed.) Citation

Klyueva, Svetlana N., et al. Possibilities and Prospects of Using Biofluorescent Proteins at the Stage of Preclinical Evaluation of Live Vaccines, Using the Example of the <i>Yersinia Pestis</i> Vaccine Strain EV NIIEG PTURBOGFP-B. Central Research Institute for Epidemiology, 2025.